Pivekimab 是一种靶向白介素 3 (IL-3) 的人 IgG1 单克隆抗体。Pivekimab 是一种靶向CD123的抗体-药物结合物。Pivekimab 可用于母细胞浆细胞样树突状细胞肿瘤 (BPDCN) 的研究。
| 生物活性 | Pivekimab is a human monoclonalIgG1antibody targetinginterleukin 3 (IL-3). Pivekimab is aCD123-targeting antibody-drug conjugate. Pivekimab can be used in research of blastic plasmacytoid dendritic cell neoplasm (BPDCN)[1]. |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
